JSE-listed ASP Isotopes expands into US nuclear fuel market

JSE-listed ASP Isotopes (ASPI) on Tuesday announced its nuclear fuels subsidiary Quantum Leap Energy will establish its global headquarters in Austin, Texas, as the group expands its presence in advanced nuclear fuel markets.

The move to base the subsidiary in Austin comes shortly after the US-based company secured a secondary listing on the JSE through its acquisition of Renergen.

ASPI said the Texas headquarters will support Quantum Leap Energy’s role in developing technologies across the nuclear fuel cycle, including uranium enrichment, isotope production and waste treatment.

Uranium enrichment is the process of increasing the concentration of the specific uranium isotope so it can be used as fuel in nuclear reactors.

The company is targeting the growing demand for high-assay low-enriched uranium (Haleu), a specialised fuel required by many next-generation nuclear reactors and small modular reactor designs.

Supply constraints around Haleu have become a key issue in the global nuclear sector, particularly as Western countries seek alternatives to Russian enrichment services.

Demand to ramp up

According to the company’s projections, US demand for Haleu could increase significantly over the next two decades as advanced nuclear projects move towards commercial deployment.

Beyond the headquarters, Quantum Leap Energy plans to establish a broader operational footprint in Texas through a proposed joint venture with Fermi America, a US energy infrastructure firm developing a private electricity grid aimed at supporting artificial intelligence and high-performance computing demand.

The company said the partnership centres on plans to develop a Haleu enrichment research and production facility, alongside a commercial plant focused on stable isotopes and advanced nuclear materials at an energy campus in Amarillo, Texas. The company did not disclose expected investment levels, timelines or regulatory approval requirements for the planned facilities.

Besides the US expansion strategy, ASPI continues to maintain operations in South Africa, where it runs isotope enrichment facilities in Pretoria.

The company said it remains engaged with regulators regarding potential uranium enrichment initiatives locally and continues collaboration with the South African Nuclear Energy Corporation. ASPI’s proprietary aerodynamic separation technology draws on South Africa’s historical expertise in isotope separation, which the company is seeking to commercialise internationally.